Clinical Trial Update: Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating combination chemotherapy with filgrastim for locally recurrent or advanced urothelial cancer, including bladder cancer and cancers of t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Transitional Cell Carcinoma of the Renal Pelvis and Ureter

Drugs mentioned

• Filgrastim (filgrastim)

Snippet

Sponsor: Amgen | Conditions: Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter | Phase 2 | Status: UNKNOWN